We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.32B
AUM Growth
+$263M
Cap. Flow
+$81.3M
Cap. Flow %
1.53%
Top 10 Hldgs %
24.53%
Holding
923
New
177
Increased
263
Reduced
239
Closed
141

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$30.8M
2
WP
Worldpay, Inc.
WP
+$19.5M
3
UNP icon
Union Pacific
UNP
+$15.4M
4
DG icon
Dollar General
DG
+$13.1M
5
SBUX icon
Starbucks
SBUX
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.66%
2 Technology 16.19%
3 Consumer Discretionary 13.83%
4 Financials 12.22%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BURL icon
51
Burlington
BURL
$22B
$37.8M 0.71%
466,929
+247,829
+113% +$19.2M
BX icon
52
Blackstone
BX
$104B
$36.5M 0.69%
1,429,009
+273,565
+24% +$7.22M
FRC
53
DELISTED
First Republic Bank
FRC
$33.5M 0.63%
434,088
+1,319
+0.3% +$97K
BFH icon
54
Bread Financial
BFH
$4.21B
$33.2M 0.62%
193,903
-24,942
-11% -$4.25M
BMY icon
55
Bristol-Myers Squibb
BMY
$127B
$33M 0.62%
611,643
-479,551
-44% -$30.8M
EQIX icon
56
Equinix
EQIX
$107B
$31M 0.58%
85,987
+413
+0.5% +$153K
SIX
57
DELISTED
Six Flags Entertainment Corp.
SIX
$29.6M 0.56%
552,710
-26,363
-5% -$1.42M
REGN icon
58
Regeneron Pharmaceuticals
REGN
$68.8B
$27.9M 0.52%
69,406
-180
-0.3% -$72.2K
JCI icon
59
Johnson Controls International
JCI
$87.5B
$27.5M 0.52%
591,208
+562,188
+1,937% +$26.1M
WHR icon
60
Whirlpool
WHR
$2.42B
$27.3M 0.51%
168,122
-1,385
-0.8% -$245K
ACHC icon
61
Acadia Healthcare
ACHC
$3.17B
$26.3M 0.49%
531,020
-56,405
-10% -$2.94M
ULTI
62
DELISTED
Ultimate Software Group Inc
ULTI
$25.9M 0.49%
126,499
-1,216
-1% -$257K
COR
63
DELISTED
Coresite Realty Corporation
COR
$25.7M 0.48%
347,738
+947
+0.3% +$76.8K
ABT icon
64
Abbott
ABT
$180B
$25.3M 0.48%
599,191
+485,019
+425% +$20.8M
BLK icon
65
Blackrock
BLK
$164B
$25.3M 0.47%
69,698
-115
-0.2% -$41.8K
HON icon
66
Honeywell
HON
$77.1B
$25M 0.47%
238,694
-8,504
-3% -$889K
ELLI
67
DELISTED
Ellie Mae Inc
ELLI
$24.8M 0.47%
235,772
+205,611
+682% +$19.9M
CMG icon
68
Chipotle Mexican Grill
CMG
$40.8B
$24.5M 0.46%
2,896,400
-178,000
-6% -$1.46M
UNP icon
69
Union Pacific
UNP
$183B
$24.4M 0.46%
250,621
-164,506
-40% -$15.4M
DOC
70
DELISTED
PHYSICIANS REALTY TRUST
DOC
$24.4M 0.46%
1,132,354
-1,573
-0.1% -$33.3K
CVS icon
71
CVS Health
CVS
$137B
$22.9M 0.43%
257,478
-112,719
-30% -$10.6M
AVY icon
72
Avery Dennison
AVY
$12.3B
$22.6M 0.42%
290,639
+1,059
+0.4% +$80.9K
RTN
73
DELISTED
Raytheon Company
RTN
$22.3M 0.42%
163,942
+159,739
+3,801% +$22.2M
GWRE icon
74
Guidewire Software
GWRE
$11.5B
$19.3M 0.36%
322,214
+206,144
+178% +$12.7M
V icon
75
Visa
V
$676B
$18.6M 0.35%
224,453
-1,347
-0.6% -$108K

Similar funds

Geneva Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Geneva Advisors held 923 positions worth $5.32B, up 5.2% from $5.06B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q3 2016 filing shows 177 new, 263 increased, 239 reduced and 141 closed positions. Its largest new stake was A.O. Smith: 245,940 shares worth $12.1M. The largest sale was Bristol-Myers Squibb, an estimated $30.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Geneva Advisors's largest Q3 2016 buy was A.O. Smith: 245,940 shares worth $12.1M.
  • Geneva Advisors added most to Johnson Controls International in Q3 2016, an estimated $26.1M increase.
  • Geneva Advisors's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $30.8M.
  • Geneva Advisors fully exited McKesson in Q3 2016, selling an estimated $6.69M.
  • Geneva Advisors's ten largest holdings make up 25% of its $5.32B portfolio in Q3 2016.
  • Geneva Advisors opened 177 new positions and closed 141 in Q3 2016.
  • Geneva Advisors's portfolio value rose 5.2% quarter-over-quarter to $5.32B.

Based on Geneva Advisors's 13F filing for Q3 2016, filed 9 Nov 2016.